-
.jpg?crop=yes&w=210&h=209&itok=aFjfCXoL "eCOA best practices guide.")
Best practices to keep eCOA implementation off the critical path of clinical trial startup.
This blog post details eCOA implementation best practices: key steps and solutions to keep eCOA off the critical path of clinical trial startup.
-
Patient-Reported Outcomes as Endpoints in Oncology Labeling Claims: An FDA/EMA Perspective
This blog post details the differences in approaches between FDA and EMA that are critical for sponsors to develop PRO strategies for drug labeling claims.
In this section